Stock MAAT MAAT PHARMA
Add to a list
To use this feature you must be a member
Log inSign up

Consensus MaaT Pharma

Equities

MAAT

FR0012634822

Market Closed - Euronext Paris
Other stock markets
 05:35:14 26/04/2024 pm IST 		5-day change 1st Jan Change
9.06 EUR 0.00% Intraday chart for MaaT Pharma +3.90% +29.80%
15/04 MaaT Pharma: positive data in graft-versus-host disease CF
15/04 MaaT Pharma Presents Positive 18-Month Data for MaaT013 Showing a Clear Overall Survival Advantage in aGvHD from the Early Access Program at the 2024 EBMT Event CI

Evolution of the average Target Price on MaaT Pharma

Price target over the last 5 years

History of analyst recommendation changes

b077.47g32rTW1IPh9ST9_DGLfoDYHHomOlelqdYnOakisfw.0ftu4tmltvWwu2bNsQT_McSUWRFCfjmc45xGT8No4MSKwEfsxLic6tLFbQ~e3b2a6fe7d8e2e17b7809ac0ca1b5a54

Analyst Recommendations on MaaT Pharma

Fragmented feeling? Our Logo
But where have the bears gone? Our Logo
MaaT Pharma's Immune Disorder Therapy Shows Improved Survival Rate In Clinical Trials MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
9.06 EUR
Average target price
15.5 EUR
Spread / Average Target
+71.08%
High Price Target
16 EUR
Spread / Highest target
+76.60%
Low Price Target
15 EUR
Spread / Lowest Target
+65.56%

Consensus detail

Consensus revision (last 18 months)

Ratings for MaaT Pharma

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MAAT Stock
  4. Consensus MaaT Pharma